AnalystBook Research · Company Intelligence

Blue Water Acquisition Corp. III

BLUWNasdaq

Built from Blue Water Acquisition Corp. III's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Blue Water III is a SPAC shell focused on a future combination, with no revenue and a deeper equity deficit in FY2025.

The read at a glance✓ Audited against SEC data
  • Business mixBlank-check SPAC shellNote
  • FocusBiotech, healthcare, tech focusNote
  • RevenueNo revenue taggedNote
  • IncomeNet income $4.7MNote
  • EquityEquity deficit -$8.9MWatch
  • Insiders0 purchases / 2 salesWatch
  • AccountingForensic screens unavailableNote

Business

Blue Water Acquisition Corp. III is a Cayman Islands blank-check company formed to pursue a business combination.

Leadership changes

From Blue Water Acquisition Corp. III's own filings, the day they're filed.

  • Timothy N. Coulson · directors · appointmenteff. 2025-06-09
  • Laurent D. Hermouet · directors · appointmenteff. 2025-06-09
  • Ish S. Dugal · directors · appointmenteff. 2025-06-09

Latest filings

  • 8-K · Company announcement2026-08-12
  • 10-Q · Quarterly report2026-08-12
  • 10-Q · Quarterly report2026-05-15
  • 10-K · Annual report2026-04-14
  • 8-K · Company announcement2026-01-27
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Blue Water Acquisition Corp. III, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.